Literature DB >> 16450368

Quantitative myocardial infarction on delayed enhancement MRI. Part II: Clinical application of an automated feature analysis and combined thresholding infarct sizing algorithm.

Li-Yueh Hsu1, W Patricia Ingkanisorn, Peter Kellman, Anthony H Aletras, Andrew E Arai.   

Abstract

PURPOSE: To compare global and regional myocardial infarction (MI) measurements on clinical gadolinium-enhanced magnetic resonance (MR) images using human manual contouring and a computer algorithm previously validated by histopathology, and to study the degree to which visual assessment and human contouring of infarct extent agreed with the computer algorithm.
MATERIALS AND METHODS: Infarct size in 20 patients was measured by human manual contouring and with an automated feature analysis and combined thresholding (FACT) computer algorithm. Short-axis slices were divided into myocardial sectors for regional analysis. Extent of infarction was also graded visually by consensus of expert readers and compared to human and computer contouring.
RESULTS: Despite good correlations (R = 0.93-0.95) between human contouring and the FACT algorithm, human contouring overestimated infarct size by 3.8% of the left ventricle (23.8% of the MI) area (P < 0.001). Human contouring also overestimated the circumferential extent, transmural extent, and extent of infarction within a sector by 7.1%, 18.2%, and 27.9%, respectively (all P < 0.001). Both consensus reading and human contouring overestimated infarct grades compared with the FACT algorithm (P = 0.002 and P < 0.001).
CONCLUSION: Clinically relevant overestimation of MI can occur in visual interpretation and in human manual contouring, particularly with respect to extent of infarction on a regional basis. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16450368     DOI: 10.1002/jmri.20495

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  26 in total

1.  Reliability of myocardial salvage assessment by cardiac magnetic resonance imaging in acute reperfused myocardial infarction.

Authors:  Steffen Desch; Hubertus Engelhardt; Josefine Meissner; Ingo Eitel; Mahdi Sareban; Georg Fuernau; Suzanne de Waha; Matthias Grothoff; Matthias Gutberlet; Gerhard Schuler; Holger Thiele
Journal:  Int J Cardiovasc Imaging       Date:  2011-01-30       Impact factor: 2.357

2.  Automated scar quantification by CMR: a step in the right direction.

Authors:  Steven K White; Andrew S Flett; James C Moon
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

3.  Quantitation of infarct size in patients with chronic coronary artery disease using rest-redistribution Tl-201 myocardial perfusion SPECT: correlation with contrast-enhanced cardiac magnetic resonance.

Authors:  David S Fieno; Louise E J Thomson; Piotr Slomka; Aiden Abidov; John D Friedman; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

4.  Controversies in cardiovascular MR imaging: reasons why imaging myocardial T2 has clinical and pathophysiologic value in acute myocardial infarction.

Authors:  Andrew E Arai; Steve Leung; Peter Kellman
Journal:  Radiology       Date:  2012-10       Impact factor: 11.105

5.  Myocardial scar identification based on analysis of Look-Locker and 3D late gadolinium enhanced MRI.

Authors:  Qian Tao; Hildo J Lamb; Katja Zeppenfeld; Rob J van der Geest
Journal:  Int J Cardiovasc Imaging       Date:  2014-03-19       Impact factor: 2.357

Review 6.  Cardiac imaging techniques for physicians: late enhancement.

Authors:  Peter Kellman; Andrew E Arai
Journal:  J Magn Reson Imaging       Date:  2012-09       Impact factor: 4.813

7.  How to quantify infarct size on delayed-enhancement MR images: a comparison between visual and quantitative approach.

Authors:  G Ligabue; F Fiocchi; S Ferraresi; A Barbieri; R Romagnoli; P Torricelli
Journal:  Radiol Med       Date:  2007-10-21       Impact factor: 3.469

8.  Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance.

Authors:  Atul R Chugh; Garth M Beache; John H Loughran; Nathan Mewton; Julius B Elmore; Jan Kajstura; Patroklos Pappas; Antone Tatooles; Marcus F Stoddard; Joao A C Lima; Mark S Slaughter; Piero Anversa; Roberto Bolli
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

9.  Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults.

Authors:  Sujata M Shanbhag; Anders M Greve; Thor Aspelund; Erik B Schelbert; J Jane Cao; Ragnar Danielsen; Guðmundur Þorgeirsson; Sigurður Sigurðsson; Guðný Eiríksdóttir; Tamara B Harris; Lenore J Launer; Vilmundur Guðnason; Andrew E Arai
Journal:  Eur Heart J       Date:  2019-02-07       Impact factor: 29.983

10.  Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome.

Authors:  Aernout M Beek; Olga Bondarenko; Farshid Afsharzada; Albert C van Rossum
Journal:  J Cardiovasc Magn Reson       Date:  2009-03-09       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.